IRENE GABRIAL: Open Payments
NPI 1710074158 · HAMILTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 17 payments from 6 companies in 2025. Trend: 2023 $467 · 2024 $247 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 4 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $103 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: VRAYLAR, ABILIFY MAINTENA, CAPLYTA, FANAPT, COBENFY, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
